Aristides Capital LLC Takes Position in Alpha Cognition, Inc. (NASDAQ:ACOG)

Aristides Capital LLC bought a new position in shares of Alpha Cognition, Inc. (NASDAQ:ACOG) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 200,000 shares of the company’s stock, valued at approximately $1,178,000. Aristides Capital LLC owned approximately 1.25% of Alpha Cognition at the end of the most recent reporting period.

Separately, Rosalind Advisors Inc. acquired a new position in shares of Alpha Cognition during the fourth quarter worth about $1,489,000.

Alpha Cognition Trading Down 3.2 %

NASDAQ:ACOG opened at $4.83 on Friday. Alpha Cognition, Inc. has a 1 year low of $4.28 and a 1 year high of $7.00. The firm has a market cap of $77.38 million, a PE ratio of -1.89 and a beta of 2.50. The business’s 50-day simple moving average is $5.73.

Alpha Cognition (NASDAQ:ACOG) last announced its quarterly earnings results on Monday, March 31st. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.48) by ($0.03).

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ACOG. HC Wainwright reaffirmed a “buy” rating and issued a $20.00 target price on shares of Alpha Cognition in a report on Monday, March 31st. Raymond James upgraded shares of Alpha Cognition to a “moderate buy” rating in a report on Tuesday, March 25th.

Alpha Cognition Profile

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.